APC Gene Function
APC Regulator Of WNT Signalling Pathway
Overview
APC is a tumour-suppressor protein within the β-catenin destruction complex. Loss of APC can stabilise β-catenin and activate WNT-responsive transcription; inherited pathogenic variants cause familial adenomatous polyposis.
Molecular Mechanism
Detailed mechanism data is not yet available for APC.
Key Pathways
- ·WNT–β-catenin signalling
- ·Cell adhesion
- ·Chromosomal segregation
Disease Associations
- ·Familial adenomatous polyposis
- ·Colorectal cancer
- ·Gardner syndrome
Research Activity
APC is an actively studied target: about 100+ clinical trials that mention it are currently recruiting on ClinicalTrials.gov. Trial activity reflects research interest, not proven benefit — designs, endpoints and populations vary widely.
Track APC trials
New and changed oncology trials, summarised in plain language each day.
Functional Partners
Common Questions About APC
What does APC do?
APC participates in WNT–β-catenin signalling, Cell adhesion, Chromosomal segregation. APC is a tumour-suppressor protein within the β-catenin destruction complex. Loss of APC can stabilise β-catenin and activate WNT-responsive transcription; inherited pathogenic variants cause familial adenomatous polyposis.
Why is APC relevant to cancer research?
Its reported relevance includes Familial adenomatous polyposis, Colorectal cancer, Gardner syndrome. The exact alteration, assay and disease context determine what a result can support.